The treatment with an anti-glycosaminoglycan antibody reduces aortic oxidative stress in a rabbit model of atherosclerosis

References

• Negi S, Anand A. Atherosclerotic coronary heart disease-epidemiology, classification and management. Cardiovasc Hematol Disord. Drug Targets 2010;10:257–261.
   Google Scholar
• Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995;15: 551–561.
   PubMed Web of Science ®Google Scholar
• Tabas I, Williams KJ, Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007;116:1832–1844.
   PubMed Web of Science ®Google Scholar
• Leopold JA, Loscalzo J. Oxidative risk for atherothrombotic cardiovascular disease. Free Radic Biol Med 2009;47: 1673–1706.
   PubMed Web of Science ®Google Scholar
• Little PJ, Ballinger ML, Osman N. Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis. Vasc Health Risk Manag 2007;3:117–124.
   PubMedGoogle Scholar
• Levy Y, Blum S, Levy AP. Antioxidants in the prevention of atherosclerosis: the importance of proper patient selection. Clin Nutr 2009;28:581–582.
   PubMedGoogle Scholar
• Fredrikson GN, Soderberg I, Lindholm M, Dimayuga P, Chyu KY, Shah PK, Nilsson J. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arterioscler Thromb Vasc Biol 2003;23:879–884.
   PubMed Web of Science ®Google Scholar
• Zeng X, Chen J, Miller YI, Javaherian K, Moulton KS. Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis. J Lipid Res 2005;46:1849–1859.
   PubMedGoogle Scholar
• Ballinger ML, Osman N, Hashimura K, de Haan JB, Jandeleit-Dahm K, Allen T, . Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo. J Cell Mol Med 2010;14:1408–1418.
   PubMed Web of Science ®Google Scholar
• Soto Y, Acosta E, Delgado-Roche L, Pérez A, Falcón V, Bécquer MA, . Antiatherosclerotic effect of an antibody that binds to extracellular matrix glycosaminoglycans. Arterioscler Thromb Vasc Biol 2012;32:595–604.
   PubMedGoogle Scholar
• Fernández-Marrero Y, Hernández T, Roque-Navarro L, Talavera A, Moreno E, Griñán T, . Switching on cytotoxicity by a single mutation at the heavy chain variable region of an anti-ganglioside antibody. Mol Immunol 2011;48: 1059–1067.
   PubMedGoogle Scholar
• Mateo de Acosta C, Moreno E, Amour K, Lombardero J, Harris W, Pérez R. Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity. Immunotechnology 1997;3: 71–81.
   PubMedGoogle Scholar
• Jellinek H, Harsing J, Füzesi S. A new model for atherosclerosis. An electron-microscopy study of the lesion induced by i.v. administered fat. Atherosclerosis 1982;43:7–18.
   Google Scholar
• Noa M, Mas R. Ateromisol y lesión aterosclerótica en conejos inducida por Lipofundín. Prog Ciencias Méd Venezuela 1992;6:14–19.
   Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976;72:248–254.
   PubMed Web of Science ®Google Scholar
• Boehringer Mannheim ed. Biochemica information. A revised biochemical reference source. Enzymes for routine. Berlin: Boehringer Mannheim; 1987.
   Google Scholar
• Sedlak J, Lindsay RH. Estimation of total, protein bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968;25:192–205.
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Gausson V, Nguyen AT, Touam M, Drueke T, Santangelo F, Descamps-Latscha B. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int 2003;64:82–91.
   PubMed Web of Science ®Google Scholar
• Erdelmeier I, Gerard-Monnier D, Yadan JC, Chaudiere J. Reactions of N-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Mechanistic aspects of the colorimetric assay of lipid peroxidation. Chem Res Toxicol 1998;11:1184–1194.
   Google Scholar
• Granger DL, Taintor RR, Boockvar KS, Hibbs JB Jr. Determination of nitrate and nitrite in biological samples using bacterial nitrate reductase coupled with the Griess reaction. Methods Enzymol 1996;7:78–83.
   Google Scholar
• Hailer S, Wolfram G, Zoller N. Changes in serum lipoproteins in humans following the infusion of a fat emulsion containing medium and long-chain triglycerides. Eur J Clin Invest 1987;17:402–407.
   PubMedGoogle Scholar
• Delgado-Roche L, Acosta E, Fraga A, Bécquer MA, Soto Y, Falcón V, . Lipofundin-induce hyperlipidemia promotes oxidative stress and atherosclerotic lesions in New Zealand White rabbits. Int J Vasc Med 2012;7:1–7.
   Google Scholar
• Hailer S, Wolfram G, Zoller N. Changes in serum lipoproteins in humans following the infusion of a fat emulsion containing medium and long-chain triglycerides. Eur J Clin Invest 1987; 17:402–407.
   PubMedGoogle Scholar
• Tani S, Watanabe I, Anazawa T. Surugadai atherosclerosis regression investigation. Effect of provastatin on malondialdehyde-modified low-density lipoprotein levels and coronary plaque regression as determined by three-dimensional intravascular ultrasound. Am J Cardiol 2005;96:1089–1094.
   Google Scholar
• Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu N, . Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients. Am J Kidney Dis 2004;45:39–47.
   Google Scholar
• Capeillère-Blandin C, Gausson V, Descamps-Latscha B, Witko-Sarsat V. Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochem Biophys Acta 2004;1689:91–102.
   PubMed Web of Science ®Google Scholar
• Zhao R, Shen GX. Functional modulation of antioxidant enzymes in vascular endothelial cells by glycated LDL. Atherosclerosis 2005;179:277–284.
   PubMed Web of Science ®Google Scholar
• Lin SJ, Shyue SK, Shih MC, Chu TH, Chen YH, Ku HH, . Superoxide dismutase and catalase inhibit oxidized low- density lipoprotein-induced human aortic smooth muscle cell proliferation: role of cell-cycle regulation, mitogen-activated protein kinases, and transcription factors. Atherosclerosis 2007;190:124–134.
   PubMedGoogle Scholar
• Maksimenko AV, Golubykh VL, Tischenko EG. Catalase and chondroitin sulfate derivatives against thrombotic effect induced by reactive oxygen species in a rat artery. Metab Engineer 2003;5:177–182.
   PubMed Web of Science ®Google Scholar
• Zhao R, Shen GX. Functional modulation of antioxidant enzymes in vascular endothelial cells by glycated LDL. Atherosclerosis 2005;179:277–284.
   PubMed Web of Science ®Google Scholar
• Pendse AA, Arbones-Mainar JM, Johnson LA, Altenburg MK, Maeda N. Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond. J Lipid Res 2009;50:S178–S182.
   Google Scholar
• Wang Y, Qiao M, Mieyal JJ, Asmis LM, Asmis R. Molecular mechanism of glutathione-mediated protection from oxidized low-density lipoprotein-induced cell injury in human macrophages: Role of glutathione reductase and glutaredoxin. Free Radic Biol Med 2006;41:775–785.
   PubMedGoogle Scholar
• Stocker R, Keaney JF Jr. New insights on oxidative stress in the artery wall. J Thromb Haemost 2005;3:1825–1834.
   PubMed Web of Science ®Google Scholar
• Hansson GK, Geng YJ, Holm J, Hardhammar P, Wennmalm A, Jennische E. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med 1994;180:733–738.
   PubMed Web of Science ®Google Scholar
• Miyoshi T, Li Y, Shih DM, Wang X, Laubach VE, Matsumoto AH, . Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice. Life Sci 2006;79:525–531.
   PubMedGoogle Scholar
• Kibbe M, Billiar T, Tzeng E. Inducible nitric oxide synthase and vascular injury. Cardiovasc Res 1999;43:650–657.
   PubMedGoogle Scholar
• Gustafsson M, Levin M, Skålén K, Perman J, Fridén V, Jirholt P, . Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase. Circ Res 2007;101:777–783.
   PubMed Web of Science ®Google Scholar
• Devlin CM, Leventhal AR, Kuriakose G, Schuchman EH, Williams KJ, Tabas I. Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression. Arterioscler Thromb Vasc Biol 2008; 28:1723–1730.
   PubMedGoogle Scholar
• Fogelstrand P, Borén J. Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis. Nutr Metab Cardiovasc Dis 2012;22:1–7.
   PubMed Web of Science ®Google Scholar